answer text |
<p>The Government’s no-deal European Union exit contingency planning covers the entire
United Kingdom and has been developed in partnership with the devolved administrations
and local National Health Service colleagues. The Department will continue to work
closely with colleagues in the devolved administrations towards achieving our objective
of ensuring a seamless supply to patients throughout the UK should we leave the EU
without a deal next March, to ensure a UK-wide, cross-Government approach to our planning.</p><p>
</p><p>Earlier this year, the Department undertook an analysis using Medicines and
Healthcare products Regulatory Agency and European Medicines Agency data on the supply
chain for all medicines. This identified those products coming to the UK from or via
the EU or wider EEA countries. We wrote to pharmaceutical companies on 23 August setting
out our contingency planning and our aim of ensuring continuity of medicines supple
for patients across the UK. We have received very good engagement from the industry
in response to our letters. The Department continues to work closely with these companies
to ensure that their UK stockpiles of medicines are sufficient to cope with any potential
delays at the border that may arise in event of a no-deal EU exit.</p>
|
|